Coenzyme-A Inc.
PPII
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | |||||
|---|---|---|---|---|---|
| Revenue | -9.82% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -9.82% | ||||
| Cost of Revenue | -8.85% | ||||
| Gross Profit | -10.38% | ||||
| SG&A Expenses | 3.29% | ||||
| Depreciation & Amortization | 0.00% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -0.93% | ||||
| Operating Income | -116.98% | ||||
| Income Before Tax | -352.83% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -352.83% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -352.83% | ||||
| EBIT | -116.98% | ||||
| EBITDA | -116.33% | ||||
| EPS Basic | -241.95% | ||||
| Normalized Basic EPS | -241.83% | ||||
| EPS Diluted | -241.95% | ||||
| Normalized Diluted EPS | -241.83% | ||||
| Average Basic Shares Outstanding | 31.08% | ||||
| Average Diluted Shares Outstanding | 31.08% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||